Pharvaris N.V. (PHVS) vs SELLAS Life Sciences Group, Inc. (SLS)

Pharvaris N.V. and SELLAS Life Sciences Group, Inc. are both Biotechnology companies. Pharvaris N.V. and SELLAS Life Sciences Group, Inc. are of similar size ($2.4B and $2.3B). Across the 9 metrics below, SELLAS Life Sciences Group, Inc. leads on 7 and Pharvaris N.V. on 2.

Valuation

Metric PHVS SLS Biotechnology median
P/E n/m n/m 7.88
P/S n/m 209.18 11.47
P/B 6.23 15.96 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 196.06 10.73
Earnings yield (9.53%) (1.81%) (28.84%)
Free cash flow yield (8.17%) (1.75%) (23.03%)

Profitability

Metric PHVS SLS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (71.50%) (39.63%) (57.72%)
Return on assets (64.43%) (36.54%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PHVS SLS Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (25.37%) 50.00% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PHVS SLS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.94 18.83 4.73
Net debt to EBITDA 1.72 2.54 0.96

Dividend

Metric PHVS SLS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PHVS SLS Biotechnology median
Market cap 2.30b 2.37b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack